Public Notice by closer2patents–Patent Pending for Invention–Applicant:CAMUS PHARMA PVT. LTD

Jan. 15, 2014 - PRLog -- Public Notice by closer2patents – Patent Pending for Invention – Applicant: CAMUS PHARMA PVT. LTD.

Our Client CAMUS PHARMA PVT. LTD. is the proprietor and applicant for the patent application in respect of ‘Formulations For Parenteral Use’, in India under patent application no. 67/DEL/2014, filed on 09/01/2014, which is the priority date for the application.

Please note that any patent filed after the priority date covering the same or substantially similar invention, shall not have the priority on this invention and consequently shall not have any legal standing, under the provisions of Patents Act, 1970 of India.

The patent application provides lyophilized formulations comprising at least a derivative of rifamycin such as Rifabutin for parenteral use, and methods of preparation and administration thereof.

We hereby notify publicly and to whomsoever it may concern that in respect of the said application and the invention covered in the application, that any attempt whether successful or unsuccessful to copy, reproduce, use, recreate, import or practice the patent pending invention or any invention substantially similar to the patent pending invention, may be in contravention of law of India, and shall attract suitable legal action on Civil as well as Criminal grounds, including claims of compensation and injunctions.

End users are informed herein and notified that they must buy, subscribe or use any product or process related to the said invention, only with proper authorization from the client.

- Applicant’s Patent Consultant & Agent

closer2patents